TrialJAMA neurology2021

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.

Ludwig Kappos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.